t.ndiaye

TL2 · Hyderabad

Contributes reviews on supplier material. Based in Hyderabad.

Joined 7 December 2024 · last posted 1d

79 posts, newest first. Showing up to 150.

Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #74 · Practice › Interactions · 27 Jul 2026 · 0 likes Answering the question post #70 raises rather than the one it answers. I keep a log for Delayed gastric emptying and oral specifically because my memory of it turned…
Irish differences from the UK position — what changed since Replied, post #7 · Regional › UK & Ireland · 21 Jul 2026 · 11 likes Pharmacy practice varies between pharmacies and is not deducible from the regulatory position. Two people can honestly report opposite experiences.
Sleep quality changes during weight loss Replied, post #19 · Wellbeing › Sleep · 15 Jul 2026 · 0 likes Useful. I have added it to my own notes with the date on it.
[2026 update] Waist circumference technique and its repeatability Replied, post #24 · Outcomes › Progress reports · 12 Jul 2026 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
[2026 update] Documenting an adverse event properly Replied, post #6 · Safety › Adverse events · 11 Jul 2026 · 32 likes The strongest argument against my own position on Documenting an adverse event, stated as well as I can state it, since nobody else has yet.
I joined for one answer and stayed for a year — what changed my mind Replied, post #66 · Start Here › Welcome · 7 Jul 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #58 · Analytics › Home & field testing · 6 Jul 2026 · 3 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
Manufacturer assistance programmes and their eligibility rules Replied, post #39 · Access › Pricing · 3 Jul 2026 · 0 likes Post #37 and I disagree about the size of the effect, not about the direction. Agreed on manufacturer assistance programmes, with one qualification that I think…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #23 · Compounds › Retatrutide · 28 Jun 2026 · 0 likes Checked the retatrutide discussion claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower…
Submitting a sample: the process end to end Replied, post #22 · Sourcing › Independent verification · 17 Jun 2026 · 0 likes I read post #18 twice before replying, because I had assumed the opposite. Blind sampling: submitting without the laboratory or seller knowing the source removes the…
Bioimpedance and hydration: why the number moves Replied, post #59 · Outcomes › Body composition · 12 Jun 2026 · 0 likes Useful. I have added it to my own notes with the date on it.
Cold solution and stinging: the simplest fix Replied, post #20 · Practice › Administration · 28 Apr 2026 · 0 likes Adding the measurement that post #17 says would settle it. On cold solution and stinging, I would rather understate and be corrected upward than overstate and be…
[2026 update] What a good consultation looks like from the other side Replied, post #26 · Clinical › Prescriber conversations · 15 Apr 2026 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
The anatomy of a question that gets answered within an hour Replied, post #19 · Start Here › How to Ask · 15 Apr 2026 · 0 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one.…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #26 · Analytics › Impurities & related substances · 10 Apr 2026 · 4 likes I would call the community position on Residual solvents and scavengers likely rather than established, and I would be comfortable defending that hedge.
[2026 update] Regional warehouse stock versus direct despatch Replied, post #36 · Sourcing › Logistics · 7 Apr 2026 · 15 likes Regional warehouse stock versus direct is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Follow-up: State-level differences that actually matter Replied, post #56 · Regional › North America · 7 Apr 2026 · 0 likes Anyone reporting an outcome should give the stated reason rather than the verdict. The reason is the part somebody else can use. That has been true for the cases I have…
About the Bloodwork category Replied, post #8 · Clinical › Bloodwork · 5 Apr 2026 · 23 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
Request declined, with reasoning — what changed since Replied, post #26 · Meta › Feature requests · 3 Apr 2026 · 13 likes Modest request: remember my sort preference per category rather than globally. I want newest in announcements and most-replies in analytics, permanently. A partial…
Grapefruit: why this class is not the class that cares Replied, post #92 · Practice › Interactions · 29 Mar 2026 · 0 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #55 · Research Methods › N-of-1 designs · 11 Mar 2026 · 0 likes Saving this. It is the version I will quote when the question comes round again.
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #29 · Compounds › Repair & healing peptides · 10 Mar 2026 · 3 likes Worth separating two things that post #28 runs together. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal — it is…
IGF-1 as a surrogate endpoint and its limitations Replied, post #9 · Compounds › Secretagogues & GH axis · 6 Mar 2026 · 0 likes Published human data on most of this family is thin, old, or from small studies with surrogate endpoints. That is a genuine limitation and it is the honest answer to…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #80 · Practice › Dosing & titration · 19 Feb 2026 · 8 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #82 · Outcomes › Progress reports · 18 Feb 2026 · 32 likes Post #80 and I disagree about the size of the effect, not about the direction. I would keep Seven-day rolling and the decision it usually gets used for separate in this…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #61 · Outcomes › Progress reports · 15 Feb 2026 · 13 likes Post #60 is right about the mechanism and I think understates the practical bit. The most useful reply I ever got about Seven-day rolling was a request to state my…
Revisiting: Absolute versus relative contraindications Replied, post #23 · Safety › Contraindications · 11 Feb 2026 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #73 · Clinical › Bloodwork · 10 Feb 2026 · 0 likes Since panel keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #60 · Pharmacology › Receptor biology · 15 Jan 2026 · 19 likes In vitro potency and clinical potency are related by a long chain of assumptions. A compound more potent at the receptor is not necessarily more effective at a…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #84 · Practice › Side effects · 12 Jan 2026 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Distinguishing expected GI effects from something that needs urgent attention Replied, post #67 · Practice › Side effects · 10 Jan 2026 · 10 likes Discontinuation for adverse effects in the published trials was not rare at the higher doses. That number belongs in any discussion of tolerability and is usually left…
About the Other compounds category Replied, post #7 · Compounds › Other compounds · 21 Dec 2025 · 3 likes Confirming post #4 from a second method, which matters more than confirming it from a second person. Several compounds discussed here have no published human…
The anatomy of a question that gets answered within an hour — the long version Replied, post #132 · Start Here › How to Ask · 23 Nov 2025 · 3 likes Adding the measurement that post #131 says would settle it. Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is not…
Sequence verification for an obscure compound: how it is done — what changed since Started this topic · Compounds › Other compounds · 21 Nov 2025 · 8 likes On the subject in the title: Sequence verification for an obscure compound: how it is done — what changed since Working notes rather than a conclusion. What changes if…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #14 · Data & Tools › Calculators · 21 Nov 2025 · 2 likes An observation about Feature request that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #14 · Compounds › Retatrutide · 18 Nov 2025 · 3 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
What a confidence interval means, from scratch — the long version Replied, post #15 · Research Methods › Statistics · 9 Nov 2025 · 5 likes The strongest argument against my own position on confidence interval, stated as well as I can state it, since nobody else has yet.
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #8 · Compounds › Oral incretins · 7 Nov 2025 · 0 likes Narrowing post #7, because the general version has more than one answer. Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is…
Amylin receptor signalling and satiety Replied, post #12 · Pharmacology › Receptor biology · 25 Oct 2025 · 16 likes That is consistent with mine, for whatever one more account is worth.
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #24 · Devices › Pens & autoinjectors · 21 Oct 2025 · 33 likes Where I part company with post #22, and it is a narrow parting. The click count on a dialled pen is a mechanical property of that pen and is not a universal unit.…
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #3 · Analytics › HPLC & UHPLC · 16 Sep 2025 · 5 likes Purity by chromatography answers "what proportion of what I detected is the intended species". It does not answer how much is in the vial, which is a separate assay.
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #116 · Data & Tools › Calculators · 14 Sep 2025 · 11 likes This follows post #114 rather than contradicting it. Where the titration planner refuses reasoning breaks down for me is the step from the group result to the…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #79 · Clinical › Special populations · 11 Sep 2025 · 0 likes Where I have landed on History of disordered eating, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
Power cut for eleven hours: how I assessed it afterwards Replied, post #36 · Practice › Storage & stability · 27 Aug 2025 · 4 likes Two people in this thread mean different things by power cut for eleven hours and are disagreeing about the definition while believing they are disagreeing about the…
Hypertension improvement and when medication needs revisiting Replied, post #11 · Clinical › Comorbidities · 16 Aug 2025 · 1 like Since hypertension improvement keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more…
When a preprint is the best available evidence and we say so Replied, post #52 · Evidence › Preprints · 13 Aug 2025 · 6 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion. That has been true…
Meeting a protein target on a suppressed appetite Replied, post #12 · Nutrition & Training › Protein & intake · 28 Jul 2025 · 32 likes The practical problem is that appetite suppression makes hitting a target genuinely hard, and "eat more protein" ignores the actual constraint. The right answer here…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 16 Jul 2025 · 0 likes Building on post #2 rather than restating it. Two people in this thread mean different things by Amylin analogue mechanism and are disagreeing about the definition…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #46 · Compounds › Semaglutide · 28 Jun 2025 · 20 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
Lipase elevation without symptoms: the interpretation problem Replied, post #2 · Clinical › Bloodwork · 24 Jun 2025 · 11 likes Narrowing the opening post, because the general version has more than one answer. What makes a result interesting: a trend across draws, a magnitude well beyond the…
Repeatability versus intermediate precision Replied, post #35 · Analytics › Method validation · 22 Jun 2025 · 1 like I came in to disagree and I am leaving without a disagreement.
Half-life, steady state, and accumulation worked through Replied, post #129 · Pharmacology › Pharmacokinetics · 17 Jun 2025 · 8 likes Post #127 is right about the mechanism and I think understates the practical bit. Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense,…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #29 · Pharmacology › Pharmacokinetics · 4 Jun 2025 · 24 likes Building on post #28 rather than restating it. Where the Clearance pathways reasoning breaks down for me is the step from the group result to the individual case. That…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #113 · Compounds › Semaglutide · 11 May 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
A claim built entirely on a subgroup analysis Replied, post #21 · Evidence › Study critique · 6 May 2025 · 17 likes Generalisability and validity are separate axes. A trial can be internally impeccable and still tell you nothing about the person asking. That is my reading. Someone…
Dizziness on standing: the ordinary explanation first Replied, post #4 · Nutrition & Training › Hydration & electrolytes · 22 Apr 2025 · 2 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
Follow-up: Documentation that appears only after payment Started this topic · Sourcing › Red flags · 14 Apr 2025 · 0 likes Posting this under the heading it deserves: Documentation that appears only after payment Everything below is what sits behind that. Proposing that Documentation…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #34 · Compounds › Secretagogues & GH axis · 31 Mar 2025 · 0 likes Picking up post #31: that is the part I would want checked first. Research-use-only secretagogues are not approved for human use. That statement is doing real work in…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #133 · Access › International · 30 Mar 2025 · 0 likes Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end. It is the kind of thing that is…
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #29 · Sourcing › Vendor reports · 27 Mar 2025 · 20 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. I would treat the number as…
Why cagrilintide alone is discussed so much less than in combination Replied, post #44 · Compounds › Cagrilintide & amylin analogues · 27 Mar 2025 · 10 likes Post #43 answers the question as asked. The question underneath it is different. Where I would push back on the cagrilintide alone consensus is the confidence, not the…
Maintainer handover: how it works Replied, post #48 · Meta › Wiki maintenance · 16 Mar 2025 · 14 likes Volunteering for the review on this one. I use it monthly, I have a list of three things that have aged badly, and I am willing to be named as the second maintainer.
Cost per milligram, computed honestly across formats — the long version Replied, post #35 · Access › Pricing · 16 Mar 2025 · 9 likes Taking post #32 at face value and following it one step further. Nothing here is financial advice and none of it is a route to a transaction.
Follow-up: Requesting a page: what makes a good request Replied, post #9 · Documentation › Wiki requests · 11 Mar 2025 · 0 likes Narrowing post #6, because the general version has more than one answer. A document with no maintainer becomes wrong quietly, which is worse than not existing, because…
Why mass spectrometry cannot tell you about an epimer Replied, post #79 · Analytics › Mass spectrometry · 6 Mar 2025 · 0 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #41 · Practice › Reconstitution · 25 Feb 2025 · 0 likes Picking up post #38: that is the part I would want checked first. A request rather than an answer: could whoever has the primary source for 5 mg vial post it? I have…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #90 · Compounds › Semaglutide · 22 Jan 2025 · 0 likes Worth separating two things that post #86 runs together. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people…
Follow-up: Individual participant data versus aggregate data Replied, post #84 · Evidence › Meta-analyses · 11 Jan 2025 · 3 likes Post #81 is right about the mechanism and I think understates the practical bit. Source for the Individual participant data versus aggregate figure, since it was asked…
EMA product information as a primary source — does this still hold? Replied, post #35 · Regional › European Union · 15 Nov 2024 · 6 likes Confirming post #34 from a second method, which matters more than confirming it from a second person. Practical answer on EMA product information, since the theoretical…
Why "any advice?" is the least effective ending for a post Replied, post #35 · Start Here › How to Ask · 14 Nov 2024 · 0 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
Identical chromatograms across two different lots Replied, post #46 · Sourcing › Red flags · 7 Nov 2024 · 0 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them.
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #95 · Compounds › Other compounds · 5 Nov 2024 · 0 likes Agreed on Melanocortin agonists, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does…
Progressive overload when the scale is falling — one year on Replied, post #117 · Nutrition & Training › Resistance training · 3 Oct 2024 · 0 likes Progressive overload looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #29 · Clinical › Bloodwork · 14 Sep 2024 · 0 likes Answering the question post #27 raises rather than the one it answers. The most useful reply I ever got about bring a laboratory was a request to state my units. It…
Correlation in a self-tracked dataset: what it can support Replied, post #90 · Research Methods › Statistics · 23 Aug 2024 · 9 likes Confirming post #89 from a second method, which matters more than confirming it from a second person. What would change my mind on correlation is a second dataset…
Signs of dehydration worth acting on Started this topic · Safety › Adverse events · 28 Jul 2024 · 42 likes Signs of dehydration worth acting on — setting out what I have, and where I think it stops being reliable. Signs of dehydration worth acting, from the point of view of…
The mass-error checker and its intended scope Replied, post #134 · Data & Tools › Calculators · 18 Jul 2024 · 1 like Post #131 answers the question as asked. The question underneath it is different. My experience of mass-error checker contradicts the reply above. I am posting it as a…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #73 · Practice › Dosing & titration · 8 Jul 2024 · 3 likes The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat…
Follow-up: Where the four-week escalation interval comes from, and what it is not Started this topic · Practice › Dosing & titration · 10 May 2024 · 0 likes Where the four-week escalation interval comes from, and what it is not Writing it up because I had to work it out twice and would rather nobody else did. A follow-up…